NCT01599065

Brief Summary

The purpose of this study is to compare the two options for management of ICDs (internal cardioverter defibrillators) in patients undergoing procedures with electrocautery: (1) programming ICD therapies "off," or (2) use of a magnet to suspend ICD therapies By comparing these two techniques the investigators hope to demonstrate the efficiency of using an ICD magnet protocol during perioperative management of patients undergoing electrocautery procedures. Secondary purposes are to gain further information on health care resources, incidence of EMI, handoff communications and to document lack of adverse events in either group. Primary objective will be: ICD therapy "off times" will be less with the use of a magnet protocol compared to an "off-on" protocol. Secondary objectives will be: (1) Healthcare resources (time and costs of skilled personnel) will be less using a magnet protocol compared to an off-on protocol, and (2) there will be no difference between adverse events in the magnet protocol compared to an off-on protocol. The incidence of EMI and number of handoff communications will be documented. The investigators hypothesis is that the number of minutes with ICD therapies "off" will be significantly less with magnet use. The investigators also expect health care resources to be less with magnet use compared to reprogramming.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2011

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 10, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 15, 2012

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
Last Updated

October 21, 2013

Status Verified

May 1, 2012

Enrollment Period

1.8 years

First QC Date

May 10, 2012

Last Update Submit

October 18, 2013

Conditions

Keywords

ICDinternal cardioverter defibrillatorelectrocautery

Outcome Measures

Primary Outcomes (1)

  • Number of minutes ICD therapy suspended will be less using a magnet protocol compared to number of minutes ICD therapy suspended using an "off-on" protocol.

    Up to 90 days

Secondary Outcomes (4)

  • Healthcare resources will be less using a magnet protocol compared to an "off-on" protocol. Measures: Cost in dollars

    Up to 90 days

  • There will be no difference between adverse events using the magnet protocol compared to using an "off-on" protocol.

    Up to 90 days

  • The incidence of EMI will be documented in relation to surgical locations: head/neck, thorax, abdomen/pelvis, upper extremity, lower extremity.

    Up to 90 days

  • Number of handoff communication quantified.

    Up to 90 days

Study Arms (2)

Magnet

group treated by disabling ICD during procedure

Other: Magnet or Off-On

Off-On

Group having ICD turned off during the procedure

Other: Magnet or Off-On

Interventions

Randomized to ICD suspension using a magnet or turning the ICD off and then back on.

MagnetOff-On

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who have an ICD and are patients at Edward Hospital or Advocate Good Samaritan undergoing surgical, endoscopic and interventional radiologic procedures will be considered for the study. Hospital and cardiology practice staff will identify potential subjects by reviewing surgical, endoscopic and interventional radiologic procedure schedules. When patients with an ICD are identified research staff will be notified. Any scheduled adult patient with a past medical history of an ICD will be considered for participation. If electrocautery is anticipated for the procedure this patient will be screened for the study.

You may qualify if:

  • Age \> 18 years
  • Have a pectorally implanted ICD
  • Be scheduled for surgical procedure with anticipated electrocautery, OR
  • Be scheduled for endoscopic procedure with anticipated electrocautery, OR
  • Be scheduled for interventional radiology procedure with anticipated electrocautery
  • Have a planned procedure with anticipated EC \> 15 cm (6 in) from ICD generator\*
  • Have an ICD from the following manufacturer:
  • Medtronic, Inc., OR
  • Boston Scientific (formerly Guidant/CPI), OR
  • St. Jude Medical
  • Be able to speak and understand English
  • Be willing to sign consent form
  • While subjects having procedures \< 15 cm (6 in) from generator will be excluded from the main study they will qualify to be placed in the registry.

You may not qualify if:

  • Be scheduled for a surgical, endoscopic or radiologic procedure where electrocautery is not anticipated
  • Be scheduled for a surgical, endoscopic or radiologic procedure where only bipolar electrocautery is planned (ophthalmologic procedures)
  • Have an ICD from Boston Scientific under Product Advisory related to magnet performance.
  • Have an ICD from the manufacturer ELA or Biotroniks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Advocate Good Samaritan Hospital

Downers Grove, Illinois, United States

Location

Elmhurst Memorial Hospital

Elmhurst, Illinois, United States

Location

Edward Hospital

Naperville, Illinois, 60540, United States

Location

MeSH Terms

Conditions

Death, Sudden, CardiacArrhythmias, CardiacHeart Failure

Interventions

Magnets

Condition Hierarchy (Ancestors)

Heart ArrestHeart DiseasesCardiovascular DiseasesDeath, SuddenDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Manufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Janet Gifford, MSN, APN

    Edward Hospital/Midwest Heart Foundation

    PRINCIPAL INVESTIGATOR
  • Karen Larimer, PhD, ACNP

    Midwest Heart Specialists-Advocate Medical Group

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

May 10, 2012

First Posted

May 15, 2012

Study Start

December 1, 2011

Primary Completion

October 1, 2013

Study Completion

October 1, 2013

Last Updated

October 21, 2013

Record last verified: 2012-05

Locations